Novo Nordisk shares rose after the Danish obesity-drug maker's first-quarter earnings topped Wall Street expectations. As widely anticipated, the drug maker reduced its growth forecast to reflect the ...

Novo Nordisk stock jumped early Wednesday despite cutting its 2025 outlook due to what Novo says is illegal compounding of ...

Shares of Novo Nordisk climbed nearly 7% on Wednesday after the company said sales of its obesity drug Wegovy are expected to ...

Pharmaceutical company Charles River Laboratories has reached a settlement with activist investor Elliott Investment ...

Gilead Sciences announced $11 billion in new planned investment in the U.S. to boost its domestic manufacturing and research ...

Recent actions by President Donald Trump's administration, including staff cuts at the Food and Drug Administration, have ...

Federal health agencies will create a database of autism patients enrolled in Medicare and Medicaid that researchers will use ...

The U.S. Food and Drug Administration said on Wednesday it will hold a meeting of experts to discuss COVID-19 vaccine ...

A U.S. federal judge has sided with a U.S. regulator's decision last year to take Eli Lilly’s blockbuster weight loss and ...

U.S. Agriculture Secretary Brooke Rollins said during a hearing in the House of Representatives on Wednesday that new dietary ...

As Novo Nordisk works through a period of transition in the U.S. GLP-1 drug market, sales from the company's star obesity ...

India's central bank on Wednesday laid down a framework to standardise the process of making and amending rules, including ...